Cells transfected with TSP2-silencing sequence exhibited increased apoptosis. »
03/07/22

Anti-PSMA immunostaining: proposed standardized marker for identifying residual cancer. »
03/01/22

Afatinib demonstrated activity against tumors harboring major uncommon mutations. »
12/28/21

5-year disease-free survival rate in open group 63.2% versus 77.6% in minimally invasive group. »
11/17/21

C5S-A observable for more than 3 days with single staining. »
01/06/22

Network-level approaches powerful way to address lesion-symptom mapping problem. »
09/23/21

Three biomarkers (PCDH17, POU4F2 and PENK) selected to construct new panel. »
08/26/21

Novel synergistic combinations that warrant evaluation in future studies. »
11/18/21

PI3K signaling as novel druggable target in OCSC. »
12/31/21

Greater adiposity in childhood and, to a lesser extent, early adulthood, associated with reduced risk. »
03/08/22